These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 39353392)

  • 1. Hepatoprotective effects of vildagliptin mitigates lung biochemical and histopathological changes in experimental hepatopulmonary syndrome model in rat.
    Mangoura SA; Ahmed MA; Hamad N; Zaka AZ; Khalaf KA
    Int Immunopharmacol; 2024 Dec; 143(Pt 1):113254. PubMed ID: 39353392
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vildagliptin ameliorates intrapulmonary vasodilatation and angiogenesis in chronic common bile duct ligation-induced hepatopulmonary syndrome in rat.
    Mangoura SA; Ahmed MA; Hamad N; Zaka AZ; Khalaf KA; Mahdy MA
    Clin Res Hepatol Gastroenterol; 2024 Aug; 48(7):102408. PubMed ID: 38925324
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tea polyphenols and Levofloxacin alleviate the lung injury of hepatopulmonary syndrome in common bile duct ligation rats through Endotoxin -TNF signaling.
    Zhu J; Qiu J; Chen K; Wang W; Zheng S
    Biomed Pharmacother; 2021 May; 137():111263. PubMed ID: 33516071
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of CX₃CL1/CX₃CR1 in pulmonary angiogenesis and intravascular monocyte accumulation in rat experimental hepatopulmonary syndrome.
    Zhang J; Yang W; Luo B; Hu B; Maheshwari A; Fallon MB
    J Hepatol; 2012 Oct; 57(4):752-8. PubMed ID: 22659346
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of receptor tyrosine kinase activation in cholangiocytes and pulmonary vascular endothelium in experimental hepatopulmonary syndrome.
    Yang W; Zhang J; Hu B; Wu W; Venter J; Alpini G; Fallon MB
    Am J Physiol Gastrointest Liver Physiol; 2014 Jan; 306(1):G72-80. PubMed ID: 24200956
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rosuvastatin improves hepatopulmonary syndrome through inhibition of inflammatory angiogenesis of lung.
    Chang CC; Wang SS; Hsieh HG; Lee WS; Chuang CL; Lin HC; Lee FY; Lee SD; Huang HC
    Clin Sci (Lond); 2015 Sep; 129(6):449-60. PubMed ID: 25940601
    [TBL] [Abstract][Full Text] [Related]  

  • 7. AMD3100 treatment attenuates pulmonary angiogenesis by reducing the c-kit (+) cells and its pro-angiogenic activity in CBDL rat lungs.
    Shen CC; Chen B; Gu JT; Ning JL; Zeng J; Yi B; Lu KZ
    Biochim Biophys Acta Mol Basis Dis; 2018 Mar; 1864(3):676-684. PubMed ID: 29233725
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of Caffeine Treatment on Hepatopulmonary Syndrome in Biliary Cirrhotic Rats.
    Chang CC; Chuang CL; Tsai MH; Hsin IF; Hsu SJ; Huang HC; Lee FY; Lee SD
    Int J Mol Sci; 2019 Mar; 20(7):. PubMed ID: 30925782
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TNF-α neutralization improves experimental hepatopulmonary syndrome in rats.
    Liu L; Liu N; Zhao Z; Liu J; Feng Y; Jiang H; Han D
    Liver Int; 2012 Jul; 32(6):1018-26. PubMed ID: 22672643
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Caspase-3 inhibition prevents the development of hepatopulmonary syndrome in common bile duct ligation rats by alleviating pulmonary injury.
    Chen B; Ning JL; Gu JT; Cui J; Yang Y; Wang Z; Zeng J; Yi B; Lu KZ
    Liver Int; 2015 Apr; 35(4):1373-82. PubMed ID: 25113058
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CXCR2 is involved in pulmonary intravascular macrophage accumulation and angiogenesis in a rat model of hepatopulmonary syndrome.
    Li X; Chen Y; Chang Y; Li S; Zhao Z; Zhang H
    Clin Sci (Lond); 2017 Jan; 131(2):159-168. PubMed ID: 27879294
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of splenic reservoir monocytes in pulmonary vascular monocyte accumulation in experimental hepatopulmonary syndrome.
    Wu W; Zhang J; Yang W; Hu B; Fallon MB
    J Gastroenterol Hepatol; 2016 Nov; 31(11):1888-1894. PubMed ID: 27029414
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quercetin alleviates pulmonary angiogenesis in a rat model of hepatopulmonary syndrome.
    Li X; Chen Y; Wang L; Shang G; Zhang C; Zhao Z; Zhang H; Liu A
    Braz J Med Biol Res; 2016 Jul; 49(7):. PubMed ID: 27383124
    [TBL] [Abstract][Full Text] [Related]  

  • 14. N-acetylcysteine effects on genotoxic and oxidative stress parameters in cirrhotic rats with hepatopulmonary syndrome.
    Vercelino R; Tieppo J; Dias AS; Marroni CA; Garcia E; Meurer L; Picada JN; Marroni NP
    Basic Clin Pharmacol Toxicol; 2008 Apr; 102(4):370-6. PubMed ID: 18341514
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sorafenib treatment improves hepatopulmonary syndrome in rats with biliary cirrhosis.
    Chang CC; Chuang CL; Lee FY; Wang SS; Lin HC; Huang HC; Teng TH; Hsu SJ; Hsieh HG; Lee SD
    Clin Sci (Lond); 2013 Apr; 124(7):457-66. PubMed ID: 23043394
    [TBL] [Abstract][Full Text] [Related]  

  • 16. M2 macrophage accumulation contributes to pulmonary fibrosis, vascular dilatation, and hypoxemia in rat hepatopulmonary syndrome.
    Chen B; Yang Y; Yang C; Duan J; Chen L; Lu K; Yi B; Chen Y; Xu D; Huang H
    J Cell Physiol; 2021 Nov; 236(11):7682-7697. PubMed ID: 34041750
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alleviation of remote lung injury following liver ischemia/reperfusion: Possible protective role of vildagliptin.
    Sherif IO; Al-Shaalan NH
    Int Immunopharmacol; 2021 Feb; 91():107305. PubMed ID: 33388732
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Placental growth factor inhibition targets pulmonary angiogenesis and represents a therapy for hepatopulmonary syndrome in mice.
    Raevens S; Geerts A; Paridaens A; Lefere S; Verhelst X; Hoorens A; Van Dorpe J; Maes T; Bracke KR; Casteleyn C; Jonckx B; Horvatits T; Fuhrmann V; Van Vlierberghe H; Van Steenkiste C; Devisscher L; Colle I
    Hepatology; 2018 Aug; 68(2):634-651. PubMed ID: 29023811
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diosmin enhances the anti-angiogenic activity of sildenafil and pentoxifylline against hepatopulmonary syndrome via regulation of TNF-α/VEGF, IGF-1/PI3K/AKT, and FGF-1/ANG-2 signaling pathways.
    Bakr AG; El-Bahrawy AH; Taha HH; Ali FEM
    Eur J Pharmacol; 2020 Apr; 873():173008. PubMed ID: 32050083
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pulmonary angiogenesis in a rat model of hepatopulmonary syndrome.
    Zhang J; Luo B; Tang L; Wang Y; Stockard CR; Kadish I; Van Groen T; Grizzle WE; Ponnazhagan S; Fallon MB
    Gastroenterology; 2009 Mar; 136(3):1070-80. PubMed ID: 19109954
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.